TW
TWST icon

TrinityPoint Wealth’s Twist Bioscience TWST Stock Holding History

TrinityPoint Wealth’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25,486
Closed -$1.94M – 237
2020
Q3 		$1.94M Buy
+25,486
New +$1.59M 0.54% 50

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TrinityPoint Wealth's TWST Position: Q4 2020 in Review

TrinityPoint Wealth sold out of Twist Bioscience (TWST) in Q4 2020, closing a stake of 25,486 shares — an estimated $1.94M sold.

TrinityPoint Wealth first reported a position in TWST in Q3 2020 and held it in 1 quarter. The position peaked at $1.94M in Q3 2020. 222 funds tracked by Wall St. Rank hold TWST as of Q4 2020.

  • TrinityPoint Wealth reported no remaining Twist Bioscience position as of Q4 2020 after selling out during the quarter.
  • TrinityPoint Wealth sold 25,486 Twist Bioscience shares in Q4 2020, an estimated $1.94M.
  • TrinityPoint Wealth first reported a position in Twist Bioscience in Q3 2020 and held it in 1 quarter.
  • TrinityPoint Wealth's Twist Bioscience position peaked at $1.94M in Q3 2020.
  • 222 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2020.

Based on TrinityPoint Wealth's 13F filing for Q4 2020, filed 10 Feb 2021.